Biodefense and Government Contracting
Non-dilutive funding for product development, industrial base expansion and biomanufacturing
BDO knows biodefense government contracting
Development of products, technologies, capabilities and facility expansion in the life science industry is capital intensive.
Federal contracts can provide non-dilutive funding to life sciences companies and nonprofits developing products and technologies to address Chemical, Biological, Radiological or Nuclear (CBRN) threats, influenza and emerging infectious diseases.
BDO’s Biodefense team affords clients a broad range of support to navigate the federal biodefense funding process: strategic guidance includes alignment with medical countermeasure priorities, technical advisement, project management, financial management and compliance services across the biodefense lifecycle.
Our team has vast experience facilitating strategic partnerships between pharma/biotech and U.S. government agencies, including HHS Administration for Strategic Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA), National Institutes of Health (NIH), Defense Threat Reduction Agency (DTRA), DOD Medical CBRN Defense Consortium (MCDC), as well as experience engaging with federal audit agencies. This enables our Biodefense team to provide exceptional service to clients in identification of appropriate funding opportunities, engagement strategies and navigation of compliance requirements when working with the U.S. government.
How BDO Can Help
Who We Serve
BDO has experience assisting clients who receive funding from a vast array of sources, including:
HHS: ASPR/BARDA, NIH, NIAID, CDC HHS: ASPR/BARDA, NIH, NIAID, CDC
DOD: DTRA, JPEO-CBD, DARPA, MCDC, MTEC
DHS CWMD
DPA, DFC
NGOs and Foreign Governments
The Biodefense Résumé Book
Looking for support to seek or manage non-dilutive funding? Our Biodefense Résumé Book details our team’s professional experience, publications, presentations, patents and more.
Life Sciences Insights
Explore our most recent resources and thought leadership.
Antibiotic Resistance – Opportunities for life sciences companies to provide solutions to this public health concern
January 30, 2023Antibiotic Resistance – Opportunities for life sciences companies to provide solutions to this public health concern
January 30, 2023Antimicrobial resistance (AMR) is a top threat to the public’s health and remains a worldwide priority.
What we learned at BARDA’s 2022 Industry Day Conference
November 22, 2022What we learned at BARDA’s 2022 Industry Day Conference
November 22, 2022Each year the Biomedical Advanced Research and Development Authority (BARDA) holds an annual Industry Day conference showcasing successful industry partnerships and providing insight into future federal interagency priorities to support product development to address public health threats. BARDA and their interagency partners provide nondilutive funding to support advanced research and development of medical countermeasures (MCMs).
What we learned at Day 2 of BARDA’s 2022 Industry Day Conference
December 19, 2022What we learned at Day 2 of BARDA’s 2022 Industry Day Conference
December 19, 2022For those in the Life Sciences space – check out Part Two of our series on key takeaways from the Biomedical Advanced Research and Development Authority (BARDA) Industry Day annual conference.
Canada Ramps Up Efforts to Eliminate Forced and Child Labor in Supply Chains
May 25, 2023Canada Ramps Up Efforts to Eliminate Forced and Child Labor in Supply Chains
May 25, 2023On May 3, 2023, the Canadian Parliament passed a bill (Bill S-211) focused on environmental, social and government (ESG) policy, entitled “An Act to Enact the Fighting Against Forced Labour and Child Labour in Supply Chains Act and to Amend the Customs Tariff” (Act).
How Healthcare and Biotech Can Benefit from New Tax Credits and Incentives
May 9, 2023How Healthcare and Biotech Can Benefit from New Tax Credits and Incentives
May 9, 2023Want to take your healthcare organization’s tax planning to the next level? Read the insight insight to learn about available tax credits and incentives.
U.S. Senate Committee Expands Alleged Forced Labor Probe Involving Major Automakers to Suppliers
April 12, 2023U.S. Senate Committee Expands Alleged Forced Labor Probe Involving Major Automakers to Suppliers
April 12, 2023The U.S. Senate Committee is expanding its probe into alleged forced labor involving major automakers to their suppliers.
BDO Biotech Brief - Q1 2023
March 27, 2023BDO Biotech Brief - Q1 2023
March 27, 20232023 will be about finding balance as the biotech industry adjusts to its new financial reality. Discover the latest updates in the industry in our Q1 Biotech Brief.
Process Validation Approach for Gene Editing Critical Materials
March 27, 2023Process Validation Approach for Gene Editing Critical Materials
March 27, 2023Learn how one company was able to develop and execute a risk and science-based approach to validation for gene editing critical materials.
Blockchain for Your Life Sciences & Healthcare Organization
March 3, 2023Blockchain for Your Life Sciences & Healthcare Organization
March 3, 2023Blockchain can be a game-changing technology for both life sciences and healthcare, as it offers opportunities for efficient collaboration, transparent data-sharing and enhanced security.
Enhance Your Network Strategy with BDO
March 2, 2023Enhance Your Network Strategy with BDO
March 2, 2023Whether you want to reduce reliance on one location, optimize and move your current locations, address shrinking operating margins, improve agility or support growth, BDO can help you achieve those goals.
2023 BDO Life Sciences CFO Outlook Survey
January 30, 20232023 BDO Life Sciences CFO Outlook Survey
January 30, 2023Read the 2023 BDO Life Sciences CFO Outlook Survey to see what the industry’s CFOs are doing to conserve cash — and what those decisions could mean for your company going forward.
Global Value Chain Solutions
January 30, 2023Global Value Chain Solutions
January 30, 2023Rethink the supply chain. Realize end-to-end value.
2022/2023 Clinical Research Organization Compensation & Turnover Insights Report
January 24, 20232022/2023 Clinical Research Organization Compensation & Turnover Insights Report
January 24, 2023The Great Resignation, which started in 2021 and built to a crescendo in 2022, is causing unheard of turnover.
A Look Ahead for Life Sciences: Predictions for the Industry in 2023
January 5, 2023A Look Ahead for Life Sciences: Predictions for the Industry in 2023
January 5, 2023Here are 8 predictions for the life sciences industry in 2023.
The State of Outsourced Mammalian and Microbial Capacity
January 3, 2023The State of Outsourced Mammalian and Microbial Capacity
January 3, 2023BDO’s bioTRAK database, which tracks supply and demand for biopharmaceutical manufacturing capacity, is showing that outsourcing in the industry isn’t going away anytime soon.
Ask These Questions Before Pursuing an M&A Transaction
November 7, 2022Ask These Questions Before Pursuing an M&A Transaction
November 7, 2022For life sciences companies, M&A and collaborations are a key strategy for growth, building product pipelines and getting products to market as quickly as possible.
Contact Us
Talk to a government contracting professional. We will respond in 1-2 business days.
Thank you for contacting BDO. A representative will be in touch shortly.
Meet Our Biodefense Industry Leader
Aaron Raddock
Partner; Government Contracting Industry National Co-Leader
Together, we thrive.
Everything we do is rooted in our core purpose to help people thrive every day. It’s not only the right business thing to do; it’s the right human thing to do. This starts by putting our people at the center of our work and extends to how we treat and value our people, our clients and our communities. With a dedication to quality and a purpose-driven culture, BDO offers a powerful choice both for clients and those seeking rewarding professional careers.